Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:CTRVP
DateTimeSourceHeadlineSymbolCompany
15/07/202422:17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/07/202414:46Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/03/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
06/03/202421:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
22/02/202401:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
22/02/202401:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
20/02/202421:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/02/202421:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/12/202313:41Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
28/11/202311:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
20/11/202320:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
31/10/202320:15Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/10/202322:22Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/10/202321:52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
20/09/202316:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
19/09/202314:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/08/202321:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/07/202322:12Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
12/05/202321:19Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/04/202321:52Edgar (US Regulatory)Annual Report (10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/04/202311:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
21/11/202222:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
14/11/202221:38Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/11/202222:21Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/11/202211:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
17/10/202222:14Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
05/08/202221:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
26/07/202221:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
25/07/202212:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
05/07/202213:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:CTRVP

Your Recent History

Delayed Upgrade Clock